The current role of paclitaxel DCB in PCI - EuroPCR 2022
DCB Coronary - Paclitaxel vs Sirolimus, Dr. Bruno Scheller
Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated ballons PREVAIL?
DCB, what you expect to see at follow-up from a “different” approach to PCI - Webinar
Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel
EuroPCR 2021 - Paclitaxel and sirolimus coated balloons: create evidence before claims
TCT 2021: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB | Prof Bruno Scheller
TOWN HALL - “LET’S TALK PACLITAXEL”
PCR statement on the future of paclitaxel drug-coated balloons – EuroPCR 2019
Are Drug Coated Balloons ready for the primetime in PCI? – Cardiovascular News x B
TCT 23: AGENT IDE: AGENT Paclitaxel Coated Balloon Angioplasty for In-Stent Restenosis
IR experts respond to new meta-analysis of paclitaxel-coated balloons in infrapopliteal arteries
Drug-coated balloons - Finally ready for primetime?! - EuroPCR 2023
Sirolimus-Coated Balloons | Clinical Updates and Potential Advantages | TCT Connect 2020 Symposium
SeQuent® Please NEO: DCB-only vs. DES in complex PCI (PCR e-Course 2020)
Go implant-free in de novo lesions: DCB-only strategy - EuroPCR 2019
DCB, when and how to use. A discussion with the experts - Webinar
Nothing to fear - a guide to combine DCB and DES in hybrid PCI - EuroPCR 2022
Stellarex drug-coated angioplasty balloon product animation
The future of PCI seems bright - The MagicTouch sirolimus-coated balloon - EuroPCR 2021
